Corvus Pharmaceuticals, Inc. (CRVS) vs HealthStream, Inc. (HSTM)
A side-by-side comparison of Corvus Pharmaceuticals, Inc. and HealthStream, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
CRVS
Corvus Pharmaceuticals, Inc.
$10.52HealthcareDelayed quote: Oct 6, 2026, 9:40 AM EDT
HSTM
HealthStream, Inc.
$31.42HealthcareDelayed quote: Oct 6, 2026, 9:40 AM EDT
Total return — CRVS vs HSTM
growth of $100 · dividends reinvested · last 10yCRVS -33.9% (-4.1%/yr)HSTM +16.2% (+1.5%/yr)HSTM compounded faster over this window
CRVS HSTM
CRVS vs HSTM: by the numbers
- •HSTM is the larger company ($918M vs $885M market cap).
- •HSTM is profitable (6.60% net margin) while CRVS runs a net loss (0.00%).
- •HSTM pays a dividend (0.43% yield), while CRVS has no payments in the available dividend history.
Metrics side by side
Valuation
| Metric | CRVS | HSTM |
|---|---|---|
| P/E ratio | N/A | 43.93 |
| Forward P/E | N/A | 42.57 |
| PEG ratio | N/A | 6.51 |
| P/S ratio | N/A | 2.86 |
| P/B ratio | 3.93 | 2.57 |
| EV / EBITDA | N/A | 12.59 |
| FCF yield | N/A | 5.32% |
Profitability
| Metric | CRVS | HSTM |
|---|---|---|
| Gross margin | 0.00% | 65.08% |
| Operating margin | 0.00% | 8.04% |
| Net margin | 0.00% | 6.60% |
| ROE | -24.02% | 5.94% |
| ROIC | -25.25% | 4.96% |
Dividends
| Metric | CRVS | HSTM |
|---|---|---|
| Dividend yield | N/A | 0.43% |
| Payout ratio | N/A | 19.01% |
Growth (annualized)
| Metric | CRVS | HSTM |
|---|---|---|
| Revenue CAGR (5Y) | N/A | 5.05% |
| EPS CAGR (5Y) | N/A | 6.75% |
| FCF CAGR (5Y) | N/A | 2.33% |
| Total return CAGR (5Y) | 17.88% | 2.34% |
Frequently asked
- Does CRVS or HSTM pay a bigger dividend?
- HSTM pays a dividend (0.43% yield), while CRVS has no payments in the available dividend history.
- Is CRVS or HSTM more profitable?
- HSTM runs the higher net margin — CRVS at 0.00% versus HSTM at 6.60%.
- How have CRVS and HSTM total returns compared?
- Over the past 10 years, CRVS delivered -4.26% and HSTM delivered 1.25% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
HealthStream P/E ratioHealthStream dividend yieldCorvus Pharmaceuticals ROEHealthStream ROECorvus Pharmaceuticals operating marginHealthStream operating marginCorvus Pharmaceuticals revenue growthHealthStream revenue growthCorvus Pharmaceuticals free cash flowHealthStream free cash flow
Corvus Pharmaceuticals & HealthStream appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.